ClinicalTrials.gg
CompletedNCT06800807METAEDUpdated Nov 6, 2026

Metacognitive Beliefs in Adolescents With Eating and Nutrition Disorders

An observational study in Feeding and Eating Disorders, sponsored by Istituto Auxologico Italiano. Completed at 1 site in Italy. Open to female participants aged 12 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Istituto Auxologico Italiano · Observational

How we know

Updated Nov 6, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
30
Ages
12 Years to 17 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 28 studies in Feeding and Eating Disorders with a site in Italy — 13 open to participants now, 13 under way, none of them phase 3. Feeding and Eating Disorders · Italy.

Enrollment
10th of 10
30 · median 109
Started
2024
with 9 others
Observational
10 of 28
5 open now
Registered
17th of 28
by date
Lead sponsor
5 of 28
Istituto Auxologico Italiano

Among the 28 studies in Feeding and Eating Disorders with a site in Italy, this one is the 10th largest by enrollment of the 10 observational ones that give a count, is one of 10 that started in 2024, is one of 10 observational ones, and was the 17th registered.

Feeding and Eating Disorders

645 studies on the registry are indexed under Feeding and Eating Disorders; 151 are open to participants now.

Browse Feeding and Eating Disorders studies →

Open to participants now

13 of the 28 studies in Feeding and Eating Disorders with a site in Italy are open now. Recruiting first, the newest first:

8 more — sign in →

All 13 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 99 Feeding and Eating Disorders studies recruiting now, 31 (31%) set no upper age limit and 66 (67%) stop at 75 or younger; 45 take children under 18; 20 take healthy volunteers.

This study: 12 Years to 17 Years · female.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 28 studies in Feeding and Eating Disorders with a site in Italy, or all of them as a file.
02

Study summary

The present study aims to study the presence of metacognitive beliefs in adolescent subjects with eating and nutrition disorders (END) compared with a control group composed of subjects of the same sex and age belonging to the general population.

03

Conditions studied

  • Feeding and Eating Disorders

Keywords

  • metabeliefs
  • metacognition
  • brooding
  • rumination
  • anorexia nervosa
  • bulimia nervosa
  • binge eating disorder
04

Who can participate

Ages eligible
12 Years to 17 Years
Sexes eligible
Female
Sampling method
Non-probability sample

Study population

36 patients aged between 12 and 17 years, females, of Italian nationality, who present a diagnosis relating to the END framework according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).

These patients will be compared with a control group made up of 36 subjects of the same sex, age, and nationality, belonging to the general population.

Eligibility criteria

Eating and nutrition disorders (END)

Inclusion Criteria:

  • Female sex
  • Age: 12 to 17 years
  • Italian nationality
  • Diagnosis relating to the END framework according to the diagnostic criteria of the (DSM-5).

Exclusion Criteria:

  • Absence of signed

Control group

Inclusion Criteria:

  • Female sex
  • Age: 12 to 17 years
  • Italian nationality

Exclusion Criteria:

  • Absence of signed Informed Consent
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
30 participants (actual)
Patient registry
No

Groups and cohorts

  • Eating and nutrition disorders (END)

    Female patients aged between 12 and 17 years, of Italian nationality, who present a diagnosis relating to the END framework according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).

    Other: Observation of several factors involved in eating and nutrition disorders

  • Control group

    Female subjects of the same age and of Italian nationality, belonging to the general population.

    Other: Observation of several factors involved in eating and nutrition disorders

Interventions

  • OtherObservation of several factors involved in eating and nutrition disorders

    Observation of symptomatology of eating and nutrition disorders, metacognitive beliefs, brooding and rumination.

06

What researchers measure

Primary outcomes

  1. Metacognitive beliefs

    Metacognition Questionnaire (MCQ-30; Cartwright-Hatton \& Wells, 1997), a self-report test composed of 30 items on a 4-point Likert scale from 1 (I do not agree) to 4 (I completely agree 'agreement)

    Time frame: Baseline

  2. Brooding

    Penn State Worry Questionnaire (PSWQ; Meyer et at., 1990), a self-report test composed of 16 items on a 5-point Likert scale from 1 (not at all typical) to 5 (very typical)

    Time frame: Baseline

  3. Rumination

    Ruminative Response Scale (RRS; Nolen-Hoeksema and Morrow, 1991), a self-report test composed of 20 items on a 4-point Likert scale from 1 (almost never) to 4 (almost always)

    Time frame: Baseline

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Jun 2024 to primary completion in Jul 2026, 24 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 6, 2026: primary completion Jun 2026 → Jul 2026 and completion Jun 2026 → Jul 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 24, 2025
First posted
Jan 30, 2025
StartActual
Jun 26, 2024
Primary completionActual
Jul 22, 2026was Jun 2026
CompletionActual
Jul 22, 2026was Jun 2026
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 6, 2026
Primary completion
Jun 30, 2026→Jul 22, 2026 (actual)
Nov 6, 2026
Study completion
Jun 30, 2026→Jul 22, 2026 (actual)
Nov 6, 2026
Enrollment
72 (estimated)→30 (actual)
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Recruiting→Completed
    Primary completion Jun 30, 2026→Jul 22, 2026 (now actual)
    Study completion Jun 30, 2026→Jul 22, 2026 (now actual)
    Enrollment 72 (estimated)→30 (actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06800807
Responsible party
Sponsor
First posted
Jan 30, 2025
Start date
Jun 26, 2024
Primary completion
Jul 22, 2026
Completion
Jul 22, 2026
Last update
Nov 6, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion